New NIAID Funding Opportunity Announcement: Partnerships for Countermeasures Against Select Pathogens (R01)
Purpose: To solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens. Application Due Date: October 3, 2016 Budget: Direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000 in […]